News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

American Society of Hematology: No Excess Bleeding With Apixaban in Hip, Knee Trial, University of Oklahoma Study


12/6/2010 6:30:19 AM

MedPageToday -- ORLANDO -- In patients undergoing hip or knee replacement surgery, postoperative treatment with the experimental anticoagulant apixaban appeared to prevent venous thromboembolism (VTE) more effectively than treatment with low molecular weight heparin, researchers said here.

Read at MedPageToday

comments powered by Disqus
   
Bleeding

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES